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In the surgical cardiac intensive care unit 
(ICU), therapeutic interventions often 
need to be done at the bedside, 
necessitating the need for a rapidly 
employable diagnostic tool for the 
cardiac intensivist.  Cardiac function and 
volume status are critical components to 
patient care.  Intravascular volume 
status is difficult to establish.  Current 
modalities use indirect methods to 
gather data which can misdirect patient 
care.  Conventional TTE and TEE are 
unsuitable for continuous and effective 
hemodynamic assessment.
Introduction
IRB approved retrospective review of 
mechanical circulatory support 
patients and post heart transplant 
patients who had ImaCor TEE 
(hTEE)  monitoring in ICU. 
3 categories of intervention based on 
hTEE
Major: Tamponade, ECMO wean
Moderate: Device wean, inotrope 
management, fluid and 
hemodynamic management
Minor: ECMO cannula placement, 
other data
Methods
N = 34 patients with hTEE monitoring
N = 21 post MCS or HTX 
• Age: 28-73, Median : 49, Sex: M: 14  F: 7
• Devices employed:6
• ECMO: 13
• Post LVAD: 9 
• Impella: 3
• Post HTX: 4
• Pts with multiple: 6
Results Financial
The cost difference between this new 
device and the traditional TEE is also 
significant ($900 USD vs $4600 USD). 
Our institution saved in excess of 
$150,000 USD with the use of this 
device instead of traditional TEE.
ImaCor hTEE
• Device : $65,000
• Probe : $900
TTE : Prof fee $185, Technical fee $2332
TEE : Prof fee $380, Technical fee $3906
Not including technician basic after hour 
call in charge of $225 per echo.
Conclusions
This device has proven to be an 
invaluable new adjunct in the ICU 
by allowing previously unobtainable 
continuous real time monitoring of 
MCS/Post HTX.  
The use of the ImaCor hTEE probe 
provides the intensivist with timely 
important clinical data that improves 
patient care and is economically 
advantageous. Using serial hTEE 
data, the clinician can reliably make 
accurate decisions in regards to 
operative interventions.
Comparative Cost of Conventional TEE 
vs. hTEE for 5 studies in 72 hours
Nicholas C.Cavarocchi,MD
Associate Professor Of Surgery
Critical Care Director, Surgical Intensive 
Care Unit
nicholas.cavarocchi@jefferson.edu
• A miniaturized TEE probe
• FDA approved
• Real time monitoring, able to use for 72 
hours continuously.
• Allows direct visualization of 
intravascular volume and cardiac 
function
• No need of anesthesia or sedation.
Contact
ImaCor hTEE Probe
Department of Surgery, Division of Cardiothoracic Surgery, Thomas Jefferson University Hospital, 
Philadelphia, PA, United States
Christopher Y. Kang, MD, Joshua K. Wong, BS, Harrison T. Pitcher, MD, Caitlyn Johnson, MD, Konrad
Sarosiek, MD, Linda Bogar, MD, Hitoshi Hirose, MD, Nicholas C. Cavarocchi, MD
Application of the Miniaturized ImaCor Trans-Esophageal (TEE) 
Probe in Heart Transplant/Mechanical Cardiac Support Patients
Pre-hTEE Dx Post-hTEE Dx Intervention
Major
(n=4, 19%)
Post Heart TX Hemodynamic Instability (n=1) Tamponade (n=1)
Operative 
Evacuation
MCS 
(ECMO/VAD) ECMO Wean (n=3)
Biventricular failure 
(n=3)
Contraindication of 
LVAD, Withdraw of 
Care
Moderate
(n=13, 
62%)
Post Heart TX Hemodynamic Instability (n=6)
RV Failure (n=4)
No Tamponade (n=2)
Increased Fluids, 
Inotrope 
management
Medical 
management
MCS 
(ECMO/VAD)
ECMO Wean (n=3) Recoverable RV function (n=3) LVAD
Hemodynamic 
Instability (n= 4)
Myocardial 
Hematoma without 
perforation (n=1)
Inadequate VAD flow 
(n=1)
RV Failure post VAD 
(n=2)
Observation
Increased VAD 
speed
Inotrope 
management
Minor
(n=4, 19%)
MCS 
(ECMO/VAD)
Hemodynamic 
Instability (n=4)
No LV thrombus (n=1)
ECMO venous 
cannula Clot (n=1 )
ECMO cannula 
malposition (n=2)
Observation
Reposition
Emergent Bedside 
Reposition
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